N. Eliyatkın Et Al. , "The Role of p95HER2 in transtuzumab resistance in breast cancer," 3rd anticancer agent development congress , İzmir, Turkey, pp.15, 2015
Eliyatkın, N. Et Al. 2015. The Role of p95HER2 in transtuzumab resistance in breast cancer. 3rd anticancer agent development congress , (İzmir, Turkey), 15.
Eliyatkın, N., AKTAŞ, S., Özgür, H., ERÇETİN, A. P., & Küpelioğlu, A., (2015). The Role of p95HER2 in transtuzumab resistance in breast cancer . 3rd anticancer agent development congress (pp.15). İzmir, Turkey
Eliyatkın, Nüket Et Al. "The Role of p95HER2 in transtuzumab resistance in breast cancer," 3rd anticancer agent development congress, İzmir, Turkey, 2015
Eliyatkın, Nüket Et Al. "The Role of p95HER2 in transtuzumab resistance in breast cancer." 3rd anticancer agent development congress , İzmir, Turkey, pp.15, 2015
Eliyatkın, N. Et Al. (2015) . "The Role of p95HER2 in transtuzumab resistance in breast cancer." 3rd anticancer agent development congress , İzmir, Turkey, p.15.
@conferencepaper{conferencepaper, author={Nüket Eliyatkın Et Al. }, title={The Role of p95HER2 in transtuzumab resistance in breast cancer}, congress name={3rd anticancer agent development congress}, city={İzmir}, country={Turkey}, year={2015}, pages={15} }